An acceptor, an aldehyde-containing glycoside of heparosan trisaccharide (GlcA-GlcNAc-GlcA-C2H4-amido-benzaldehyde32; 0.2 mg/ml, 0.27 mM), was incubated with: (i) UDP-hexosamine sugar (either natural UDP-GlcNAc or UDP-4-SH-GlcNAc analog) alone (for single sugar addition), (ii) UDP-hexosamine sugar and UDP-GlcA (for polymerization), or (iii) UDP-GlcA alone (negative control), at 5 molar excess over the acceptor concentration, with a recombinant heparosan synthase chimeric construct, PmHS-G21 (2 mg/ml, 18 µM), in 1 mM MnCl2, 50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer at pH 7.2, for 20 h at 30 °C. For the preparation of UDP-4-SH-GlcNAc monomer, the UDP-thio-sugar donor dimer 11 was first reduced by treatment with 5 mM dithiothreitol in water at 22 °C for 20 min. Reaction products were diluted 1:10 in 50% acetonitrile, 0.1% trifluoroacetic acid, and a portion was mixed in a 1:1 ratio with the matrix solution of 6-aza-2-thiothymine (5 mg/ml in 50% acetonitrile, 0.1% trifluoroacetic acid) and dried with a stream of air. The spot was assessed by matrix-assisted laser desorption/ionization time of flight (MALDI-ToF) mass spectrometry (reflector negative mode using an Ultraflex II instrument, Bruker Daltonics, Billerica, MA)21 (Supplementary Fig. 38). A ladder of defined HA oligosaccharides was employed as the mass calibrants (Hyalose, LLC, Oklahoma City, OK).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.